At the age of 7, my son Timo was diagnosed with ADHD.Timo could not attend school normally, he had great difficulties in socializing at home and in the family.He was very desperate ... and so was I.Timo was then prescribed a medication that helped him improve in his social life.But there are hardly any child-specific drugs on the market, so again there were only tablets with standard doses: 20/40/60 mg.And this was a medication where every milligram made a difference.So, I then started adjusting his dosage myself, depending on how he was feeling each day, by splitting the dose.I knew there had to be something better than dosing tablets by hand.This was the birth of PrivMed® and the moment I decided to replace the existing system of overdosing: With the personalized tablet for each patient.https://youtu.be/S7shiqhokLsI am a chemical engineer and have been working in the field of pharmaceutical machines (oral dosage forms) for 22 years.Since 2006, I have been developing concepts for innovative R&D tablet presses, including the legendary RoTab T, the RoTab Bilayer and, since 2015, the Futorque® with full containment for use in the compression of hormone and production of oncological preparations.More than 120 machines have been sold worldwide through my kg-pharma, which was founded in 2006.Users include Bayer, Reckitt-Benckiser, Alkermes, Novartis and many other pharmaceutical companies.Together with my core team René Manigk (CTO & Co-Founder) and Sebastian Aumer (Design&Communication), we have developed, patented and built the first PrivMed® ultra-compact tablet press in the last five years.Every patient has the right to the best possible treatment.And this can only be achieved if the medication is tailored precisely to the needs of each patient, whether big or small, old or young, acute or chronically ill.With PrivMed®, we are ushering in a new era of medication through tablets: Putting an end to the mass production of pharmaceuticals, to overdosing through shelf medication, to wasting valuable active pharmaceutical ingredients by throwing away unused tablets.With PrivMed® we are reinventing the tablet, for the future of personalized medication.#nextgenmedication